Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy With Topotecan for Patients With Neuroblastoma

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-12-101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy